Alaunos Therapeutics Inc. (TCRT)
NASDAQ · Healthcare
Alaunos Therapeutics Inc. Operating Income 2011–2025
Alaunos Therapeutics Inc. annual/quarterly operating income history and growth rate from 2011 to 2026. Operating income (EBIT) is profit from core business operations, excluding interest and income taxes. It reflects the efficiency of a company's core operations.
- Alaunos Therapeutics Inc. operating income for the quarter ending March 31, 2026 was -1.0 M, a 7.33% decrease year-over-year.
- Alaunos Therapeutics Inc. operating income for the twelve months ending March 31, 2026 was -4.3 M, a 65.96% decrease year-over-year.
- Alaunos Therapeutics Inc. annual operating income for 2025 was -4.2 M, a 12.20% decrease from 2024.
- Alaunos Therapeutics Inc. annual operating income for 2024 was -4.8 M, a 85.96% decrease from 2023.
- Alaunos Therapeutics Inc. annual operating income for 2023 was -34.3 M, a 2.39% decrease from 2022.
- Alaunos Therapeutics Inc. annual operating income for 2022 was -35.1 M.
Operating Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Alaunos Therapeutics Inc. Operating Income — FAQ
Alaunos Therapeutics Inc. (TCRT) operating income over the last 11 years — annual and quarterly figures with year-over-year growth and charts.
What is Alaunos Therapeutics Inc.'s operating income?
Alaunos Therapeutics Inc. (TCRT) reported operating income of -$4M for fiscal 2025.
Where can I see TCRT's operating income history?
The chart and table above show Alaunos Therapeutics Inc.'s operating income by year and by quarter, including the growth rate.